Literature DB >> 10514384

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

T Brabletz1, A Jung, S Dag, F Hlubek, T Kirchner.   

Abstract

Most colorectal cancers have loss of function mutations in the adenomatosis polyposis coli (APC) tumor suppressor gene. This leads to accumulation of beta-catenin, which together with the DNA binding protein TCF-4 functions as a transcriptional activator. Recently defined target genes are c-myc and cyclin D1, linking the APC gene defect to the capacity for autonomous proliferation of colon tumors. Here we report the identification of the matrix metalloproteinase MMP-7 as another target gene of beta-catenin/TCF-4. MMP-7 is overexpressed in 80% of human colorectal cancers and known to be an important factor for early tumor growth, with a potential function also for later progression steps, like invasion and metastasis. Our results explain the high percentage of MMP-7 overexpression in colon tumors. Moreover they indicate that defects in the APC tumor suppressor gene may also have an influence on later steps of colon tumor progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514384      PMCID: PMC1867011          DOI: 10.1016/s0002-9440(10)65204-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Structure and expression of the human gene for the matrix metalloproteinase matrilysin.

Authors:  M Gaire; Z Magbanua; S McDonnell; L McNeil; D H Lovett; L M Matrisian
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

3.  Suppression of matrilysin inhibits colon cancer cell invasion in vitro.

Authors:  H Yamamoto; F Itoh; Y Hinoda; K Imai
Journal:  Int J Cancer       Date:  1995-04-10       Impact factor: 7.396

4.  c-myc oncogene expression in colorectal cancer.

Authors:  K Sikora; S Chan; G Evan; H Gabra; N Markham; J Stewart; J Watson
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

5.  Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; W T Melvin; J E Fothergill
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

6.  Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.

Authors:  H Yamamoto; F Itoh; A Senota; Y Adachi; M Yoshimoto; T Endoh; Y Hinoda; A Yachi; K Imai
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

7.  Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.

Authors:  J P Witty; S McDonnell; K J Newell; P Cannon; M Navre; R J Tressler; L M Matrisian
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

8.  Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.

Authors:  K J Newell; J P Witty; W H Rodgers; L M Matrisian
Journal:  Mol Carcinog       Date:  1994-08       Impact factor: 4.784

9.  Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.

Authors:  M Mori; G F Barnard; K Mimori; H Ueo; T Akiyoshi; K Sugimachi
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

10.  Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers.

Authors:  M Yoshimoto; F Itoh; H Yamamoto; Y Hinoda; K Imai; A Yachi
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

View more
  199 in total

1.  Mesenchymal precursor cells.

Authors:  M Corr; N J Zvaifler
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

2.  Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation.

Authors:  T Kirchner; T Brabletz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides.

Authors:  Juliet M Daniel; Christopher M Spring; Howard C Crawford; Albert B Reynolds; Akeel Baig
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

Review 4.  Wnt pathway antagonists and angiogenesis.

Authors:  Bin Zhang; Jian-Xing Ma
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

5.  Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.

Authors:  Dan Wang; Chunsun Dai; Yingjian Li; Youhua Liu
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

6.  Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.

Authors:  Nancy Gavert; Amir Ben-Shmuel; Vance Lemmon; Thomas Brabletz; Avri Ben-Ze'ev
Journal:  J Cell Sci       Date:  2010-05-25       Impact factor: 5.285

7.  Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes.

Authors:  Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.

Authors:  J R Bebb; D P Letley; R J Thomas; F Aviles; H M Collins; S A Watson; N M Hand; A Zaitoun; J C Atherton
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.

Authors:  K Pham; T Milovanovic; R J Barr; T Truong; R F Holcombe
Journal:  Mol Pathol       Date:  2003-10

10.  Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis.

Authors:  Keiichi Iwaya; Hitoshi Ogawa; Masahiko Kuroda; Miki Izumi; Tsuyoshi Ishida; Kiyoshi Mukai
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.